mRNA vaccines aid cancer development due to the use of modified mRNA designed to suppress immunity, a study in the International Journal of Biological Macromolecules has found. The abstract summarises the findings (with my emphasis):

Due to the health emergency created by SARS-CoV-2, the virus that causes the COVID-19 disease, the rapid implementation of a new vaccine technology was necessary. mRNA vaccines, being one of the cutting-edge new technologies, attracted significant interest and offered a lot of hope.

The potential of these vaccines in preventing admission to hospitals and serious illness in people with comorbidities has recently been called into question due to the vaccines' rapidly waning immunity. Mounting evidence indicates that these vaccines, like many others, do not generate sterilising immunity, leaving people vulnerable to recurrent infections.

Additionally, it has been discovered that the mRNA vaccines inhibit essential immunological pathways, thus impairing early interferon signalling. Within the framework of COVID-19 vaccination, this inhibition ensures an appropriate spike protein synthesis and a reduced immune activation.

Evidence is provided that adding 100% of N1-methyl-pseudouridine (m1Ψ) to the mRNA vaccine [as with the Pfizer and Moderna vaccines] in a melanoma model stimulated cancer growth and metastasis, while non-modified mRNA vaccines induced opposite results, thus suggesting that COVID-19 mRNA vaccines could aid cancer development.

Based on this compelling evidence, we suggest that future clinical trials for cancers or infectious diseases should not use mRNA vaccines with a 100% m1Ψ modification, but rather ones with the lower percentage of m1Ψ modification to avoid immune suppression.

Read the full study here.

The findings add to worries that the experimental genetic drugs may be contributing to a recent surge in cancer diagnoses and deaths.
Source link